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Abstract  
Over the past 30 years, the effects of cocaine on the immune system have been subject to 
research mainly in animals, while relatively little work has been done in humans. This review 
focuses exclusively on the human work and the related findings in a way that is accessible to 
neuroscientists. The emerging picture suggests that cocaine may exert some direct effects on 
lymphocyte responses, as well as, and possibly more importantly, indirect effects via 
interactions with the sympathetic and neuroendocrine systems. Given the pressing need for 
more effective treatments for cocaine addiction and the high prevalence of medical 
complications associated with this disorder, this review leaves no doubt that drug addiction 
merits a place in the growing field of neuropsychoimmunology. 
 
 
Introduction 
Cocaine – one of the most widely consumed illicit drugs amongst young adults worldwide – 
is associated with significant harm [1]. Although the negative consequences of regular 
cocaine use are most noticeable in the domain of psychosocial functioning, attention has been 
increasingly paid to the wide range of medical complications frequently seen in chronic 
cocaine users [2;3].  Yet, the true scale of the health burden associated with the use of cocaine 
is only slowly emerging. Many cocaine-related medical complications lack specificity, and 
may only be recognized once they deteriorate into medical emergencies. However, at this late 
stage a direct link with cocaine is difficult to establish [4]. A common adverse health 
consequence in cocaine-addicted individuals is the increased transmission and progression of 
infectious diseases [4]. Understanding this particular vulnerability for infections may not only 
help to prevent the worsening of medical problems, but could also open up new avenues for 
the development of effective medical treatments for cocaine addiction, which are presently 
still lacking. This review represents an attempt to elucidate the high infection risk in cocaine 
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addiction from both a neuroscientific and an immunological perspective, with a particular 
focus on research in humans. A comprehensive introduction into the field of 
neuropsychoimmunology would be beyond the scope of this review, but can be found 
elsewhere [5-7]. Instead, our aim is to give neuroscientists a glimpse into an emerging area of 
interdisciplinary research that has the potential to broaden and improve our understanding of 
cocaine addiction.  
 
The neuroscientific perspective: 
Infections due to maladaptive behavior 
For many neuroscientists, inflammation and infection in chronic cocaine users have been 
regarded as consequential to behaviors that occur in conjunction with cocaine-related changes 
in brain function. The dopamine system is one of the best studied in cocaine addiction, as it is 
critically involved in cocaine’s highly reinforcing effects, thus determining its addictive 
properties [8]. As a central nervous stimulant, cocaine acutely increases levels of monoamines 
(specifically dopamine) by blocking their reuptake [9]. Acute cocaine intoxication is 
associated with compromised judgement and decision-making abilities, which may facilitate 
reward-seeking and risk-taking behaviors. Chronic cocaine use has been associated with a 
variety of neuroadaptive changes, resulting in reduced central dopamine neurotransmission 
[10;11] and significant abnormalities in brain structure and function [12]. Compromised 
‘higher level’ cognitive processing is thus likely to underlie the erratic and ill-judged behavior 
patterns frequently seen in cocaine-addicted individuals. No doubt risky behaviors, such as 
sharing unsterile straws and pipes or engagement in unprotected sex, increase the probability 
of contracting an infectious disease [13]. Moreover, cocaine users’ failure to avoid adversity 
[14] may not only increase the likelihood for contracting infections even further [15], but also 
explain the limited success of harm avoidance strategies in the treatment of cocaine addiction 
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[16]. A better understanding of the drug’s immunomodulatory effects might therefore be 
critical in developing more effective means of protection.  
 
The immunological perspective:  
Infections due to drug effects on cell-mediated immunity 
Cocaine not only increases monoamine levels in the brain but also in the periphery, where it 
interacts with immune cells. The neurotransmitter dopamine is thought to play a pivotal role 
in regulating immunity [17]. Dopamine receptors are expressed on various lymphocyte 
subpopulations (i.e. T-cells, B-cells and NK-cells), where they contribute to the regulation of 
proliferation, differentiation and apoptosis of these cells [18]. Through binding to the 
dopamine transporter in peripheral lymphocytes, cocaine may thus be able to directly 
modulate immune functions [19]. Dopamine has, therefore, been suggested to act as a 
mediator between the brain and the immune system, given its involvement in both [20]. 
Preclinical studies provide support for this hypothesis, showing that experimental lesions of 
the nigrostriatal dopaminergic system directly result in an increase in the number of 
circulating T-cells, B-cells, and neutrophil granulocytes in peripheral blood [21]. Clinical 
observations in neuropsychiatric disorders complement this evidence: Parkinson’s disease and 
schizophrenia, both disorders that are characterized by significant abnormalities in central 
dopamine function, show significant alterations in the proliferative response of peripheral 
lymphocytes in these patients [18]. This invites the question of whether the widely studied 
central nervous dopamine dysfunction in cocaine addiction is also accompanied by changes in 
the number, proportion and function of CD4+ and CD8+ lymphocytes, natural killer (NK) 
cells, and macrophages in the periphery.  
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Although little studied in humans, the picture emerging from the literature suggests that 
cocaine administration acutely increases the number and activity of distinct lymphocyte 
populations, including CD4+, CD8+ and NK-cells [22-24]. However, it remains unclear as to 
whether these changes are long lasting, as reports in actively using cocaine-addicted 
individuals are inconsistent [23;25]. Our own data in stimulant-addicted individuals show 
significantly higher levels of CD4- and significantly lower levels of NK-cells compared with 
healthy control volunteers, and no measurable group differences with respect to CD8 and B-
cells (Figure 1). Important to note is that these observed changes were not associated with 
differences in measures of depressed mood, although levels of depression were significantly 
higher in addicted individuals and depression itself has been associated with changes in 
immunity. Though perhaps surprising at first glance, these results are consistent with the 
notion of the dopamine-mediated control of lymphocyte function [26]. For instance, the 
significant decline in NK-cells could be explained by the suppression of NK-cell proliferation 
following prolonged dopamine-induced activation [27], which would be a plausible scenario 
in cocaine addiction. In light of the major role that NK-cells play in anti-viral immune 
defense, reduced levels of NK-cells may have repercussions on immunity. Furthermore, 
increased levels of CD4 T-cells would not be unusual following prolonged periods of 
infection.  
 
Changes in immune regulation may be reflected not only in the cell count, but also in 
alterations in the cells’ capacity to either produce or respond to cytokines. Cytokines are cell-
signaling molecules that facilitate communication between cells and regulate immune 
responses. Changes in cytokine expression may thus impact on immunity. Although several 
studies identified differences in cytokine concentration in the blood of cocaine-addicted 
individuals compared with control volunteers [28-33] (Table 1), these results are difficult to 
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interpret. Cross-sectional measurements only give a snapshot of participants’ current 
inflammatory status, without providing any details about potential causes or mechanisms 
underlying the observed deviations. Measurements of cytokine expression in response to 
cocaine exposure are more informative, as these might elucidate the functional implications of 
cocaine use on immunity and inflammation.  
  
Though only a few studies have examined blood samples after volunteers had taken cocaine, 
they consistently report anti-inflammatory effects. Cocaine administration in vivo seems to 
significantly reduce the synthesis of pro-inflammatory cytokines such as tumor-necrosis 
factor (TNF) alpha and interleukin (IL) 6 [34;35], irrespective of whether these volunteers had 
prior experiences with cocaine. By contrast, cocaine-addicted participants in our studies, who 
are using cocaine almost on a daily basis, show significantly higher levels of IL-6 compared 
with control volunteers, both in circulating blood (unpublished) as well as in saliva [15]. This 
suggests that cocaine may acutely exert anti-inflammatory effects but, when used chronically, 
may have the opposite effect, which increases the risk of systemic inflammation.  
 
The functional implications of altered cytokine secretion can be examined by experimentally 
activating immune cell populations in vitro. T-cells can be stimulated by the lectin 
phythohemagglutin (PHA), whereas innate immune cells can be stimulated by the endotoxin 
lipopolysaccharide (LPS). Cocaine administration in vivo has been shown to acutely alter the 
cytokine balance between cellular (Th1) and humoral (Th2) immunity by increasing the PHA-
stimulated secretion of interferon (IFN) gamma and decreasing the secretion of IL-10 [22]. 
Another study, which also administered cocaine to their volunteers in vivo before challenging 
their blood in vitro with LPS reported that cocaine had a significant inhibitory effect on the 
secretion of TNF- whilst preserving the secretion of IL-6 [34]. However, we could not 
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replicate the aforementioned findings in our own data, which we obtained by stimulating 
blood samples of healthy volunteers in vitro with PHA and LPS both with and without using 
cocaine as a co-stimulator. One account for the observed discrepancies in results may lie in 
the nature of conditions for cocaine exposure within different experiments: namely the 
difference between in vivo versus in vitro exposure. Cocaine exposure in vivo may enable the 
action of indirect effects of cocaine on neurotransmitters and hormones, which could mediate 
cocaine’s effect on the immune response, in a way that in vitro exposure may not capture 
[36]. 
 
Increasing the risk of infection through drug-induced physiological mechanisms  
The brain and the immune system continuously cross-talk through soluble factors including 
cytokines, hormones and neurotransmitters, in order to maintain homeostasis. Communication 
is organized along two main pathways, comprising the autonomic nervous system and the 
neuroendocrine axis [36]. Disruptions of homeostasis (by either internal or external stressors) 
activate these two pathways, resulting in increased peripheral levels of catecholamines 
(specifically noradrenaline) and cortisol respectively, which in turn activate or alter immune 
function through binding to their matching receptors on immune cells. Innervation of 
lymphoid tissue by the sympathetic system could be regarded as a direct link between the 
brain and the immune system [36]. Intriguingly, the effects of cocaine on both the 
sympathetic nervous and endocrine systems appear to mimic the stress response [35]. The 
similarities in the effects of stress and cocaine on immune cells are also exemplified by an 
increase in NK-cells, which has been reported in response to either acute stress or cocaine 
exposure [23;24;37]. Chronic stress, however, has been associated with a down-regulation in 
NK-cell activity [38], resembling our data in stimulant-addicted individuals. It is thus 
conceivable that the observed changes in NK-cells in cocaine-addicted individuals may not 
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only be attributable to cocaine’s direct effects on immune cells, but may also be due to 
cocaine’s modulatory effects on neuroendocrine hormones [35].  
 
 
 
The role of cocaine in the progression of infectious diseases 
Our growing knowledge about the immunomodulatory effects of cocaine has raised concerns 
around whether regular cocaine use may be associated not only with an increased risk for 
infections, but also with more rapid and severe progression of a contracted infectious disease. 
An interaction between the drug and a virus have been shown for the human 
immunodeficiency virus (HIV), but this may well apply to other infections too. One example 
of such an interaction involves the dopamine transporter (DAT), to which both the HIV-TAT 
protein and cocaine bind. Whilst cocaine increases extracellular levels of dopamine by 
inhibiting the DAT and thereby blocking dopamine reuptake, TAT-protein acts as an 
allosteric modulator of the DAT [39]. The increase in dopamine concentration is thought to 
result in an augmentation of inflammatory macrophages and greater permeability of the 
blood-brain-barrier, which in turn promotes the progression of HIV-associated pathology. 
Importantly, the interactions between cocaine and HIV are complex and are not limited to the 
DAT. Further mechanisms have been described including cocaine-induced enhancement of 
HIV transcription and expression [39;40]. Clearly, the use of cocaine during HIV infection 
worsens the outcome by increasing inflammation, accelerating the progression of the infection 
and promoting the development of the HIV-associated neurocognitive disorder.  
 
Possible clinical implications  
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The most obvious clinical consequences resulting from compromised immunity are an 
increased susceptibility to and accelerated progression of infectious diseases, as well as other 
medical complications, including cardiovascular and cerebrovascular disorders [41]. The 
combination of risky behavior patterns, insufficient avoidance of adversity and drug-induced 
changes to immunity may render chronic cocaine users particularly prone to developing 
medical complications with a chronic trajectory. Interventions that aim to achieve greater 
success should therefore not solely rely on users’ insight into the health risks associated with 
their drug use, but rather actively protect them from potential threats to their health that they 
will likely fail to avoid and that their immune system will struggle to fight.  
 
Not only may cocaine’s immunomodulatory effects diminish the users’ ability to fight 
infections, but it is also plausible that these immunomodulatory effects could play a part in the 
development of addiction itself. Just as the neuroendocrine effects of cocaine have been 
linked with processes such as sensitization, which enhance cocaine’s reinforcing properties 
[42], cocaine's anti-inflammatory effects might also perpetuate its regular use through 
mechanisms of negative reinforcement in individuals with systemic inflammation. Any 
activation of the peripheral immune system leads to increased peripheral concentrations of 
pro-inflammatory cytokines, which induce a syndrome of sickness behavior characterized by 
fatigue, anhedonia, anorexia, and depressed mood [43]. The short-term anti-inflammatory 
effects of cocaine may thus alleviate such inflammation-related or stress-induced discomfort, 
thereby motivating further use of cocaine.  
 
A further line of enquiry may be to consider what could lie at the roots of an individual’s 
proneness to systemic inflammation. One possible factor might be psychological stress, which 
can trigger acute inflammatory responses [44]. Childhood trauma and adversity have been 
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linked with enhanced inflammatory responsiveness to psychosocial stress [45], and both of 
these have been linked with later life depression [46]. Such histories are also common in 
cocaine-dependent individuals, which raises the question as to whether early life-stress 
mediates the vulnerability to both depression and addiction in these individuals via 
immunological mechanisms. These individuals, having faced significant adversity early in life 
[47;48] and thus developed a propensity to increased inflammatory responses, may then be 
more likely both to suffer from depression and to self-medicate with cocaine [49]. Although 
the idea of self-medication in the development of cocaine addiction is not new, the anti-
inflammatory effects of the drug have, to the best of our knowledge, not yet been considered 
within this context. 
 
Possible implications for research  
It is indisputable that the need to improve treatment for cocaine addiction is highly pressing. 
A better understanding of cocaine’s effects on immunity may shed light on new pathways for 
progress towards meeting this need by revealing mechanisms underpinning the development 
and chronicity of cocaine addiction, which may serve as targets for future interventions. 
Although this review only focuses on research conducted in humans, there is also a wealth of 
animal literature in this field. The present ambiguity of findings thus far in humans highlights 
the need for further animal research, as well as translational studies in order to apply the 
knowledge that has been acquired in animals to humans. It is also important that research in 
humans expands on the animal work by addressing clinically relevant issues such as potential 
variations in the immunomodulatory effects of cocaine at different stages of the addiction 
cycle, and how these might determine treatment outcomes.  
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As cocaine is most commonly used concurrently with other drugs, in particular with alcohol 
and opiates, it would also be critical to investigate its immunomodulatory effects in 
combination with other drugs that affect the immune system in their own way [6;50]. As we 
know from research on the central nervous system, poly-drug use relative to mono-drug use is 
associated with an amplification of adverse effects on brain structure and function (see 
Meyerhoff in this issue), and a similar effect may conceivably be mirrored in the changes 
observed in the immune system. The prolonged use of drugs is another clinically important 
aspect that requires investigation. Many patients who are seeking treatment have been using 
cocaine for many years, but the majority of studies only investigate the acute effects of the 
drug. However, the effects in chronic users are likely to differ and should be considered in 
research. Furthermore, studies addressing the long-term use of cocaine would be greatly 
enhanced by assuming a holistic approach, taking into account the multiple interacting 
systems, including the immune system, which cocaine may exert an influence on.  
 
Turning towards broader considerations, it is worth highlighting the effects of ageing on 
immune function. Like older people, cocaine users show increased susceptibility to 
inflammatory diseases and microbial infections [51]. On this basis, an improved 
understanding of cocaine-related immune adaptations may help to elucidate the relationship 
between cocaine use, accelerated brain ageing [52] and altered immunity [5]. In a similar 
vein, it is also possible that cocaine’s immunological effects may relate to other notable 
effects associated with cocaine addiction, such as low body weight and poor sleep quality. 
Future research should therefore not be restricted to the classical psychotropic actions of 
addictive drugs, but should also take into consideration the effects at multiple levels in both 
the brain and the periphery.  
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No doubt, the growing interdisciplinary field of neuropsychoimmunology offers much 
potential for progress in our understanding of brain-immune system interactions, and the 
implications for psychiatric disorders. This is an exciting new field that is opening up to 
addiction researchers, bringing opportunities to deepen our understanding and broaden our 
conceptualization of addiction as a disorder that goes beyond the bounds of the brain as a 
discrete entity, and thereby potentially paving the way for identifying new targets for the 
treatment of cocaine addiction.    
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Tables  
Table 1: List of studies that have investigated the effects of cocaine use on the human immune 
system over the past 30 years, which are highly heterogeneous in terms of the cell types/products 
being studied (cells, cytokines, chemokines), procedures conducted (in vivo / in vitro), type of 
stimulation being used (T-cell stimulation / innate), and composition of the samples analyzed 
(patients, healthy volunteers, level of dependency, state of abstinence).  
Authors Groups Measures Key Findings 
Moreira et al 
2016 [28] 
 
 12 self-reported cocaine 
users (abstinent) 
 24 healthy controls 
Serum IL6, IL10  IL6: Cocaine > Control 
 IL10: Cocaine < Control 
Araos et al 
2015 [30] 
 82 chronic cocaine users 
(abstinent) with co-morbid 
alcohol use disorder 
 65 healthy controls 
Plasma TNFα, IL1β, IL6, CX3CL1 / 
fractalkine, CCL2 / MCP-1 , CXCL12 / SDF-1  
TNFα, CCL2 / MCP-1  
CXCL12 / SDF-1: 
Cocaine < Control 
Ersche et al 
2014 [15] 
 31 cocaine-dependent men 
(not abstinent) 
 30 healthy male controls 
Saliva Il1, IL6, IL8, IL10, IL12p70, TNFα, IFN 
Serial sampling: pre/post provocation  
(2 conditions: disgust-evoking, neutral) 
Recordings: skin conductance, response time 
Questionnaires: attitudes towards disgust and 
hygiene behaviors 
Il6 baseline: 
Cocaine > Control 
IL6 disgust provocation: 
Cocaine > Control 
Levandowski 
et al 2014 
[31] 
 44 cocaine-dependent 
women (abstinent)  
 25 female healthy controls  
Plasma TNFα, sTNFRI, sTNFRII, TWEAK, 
TRAIL 
Questionnaires: childhood trauma, severity of 
tobacco smoking  
Group differences 
mediated by history of 
childhood trauma. 
Narvaez et al 
2013 [29] 
 37 cocaine-dependent  
individuals (abstinent) 
 27 healthy controls 
Serum Il1, IL6, TNFα, IL8, IL10, IL12p70, 
BDNF, TBARS, PCC 
IL1ß, TNFα, BDNF: 
Cocaine > Control 
Fox et al  
2012 [53] 
 28 cocaine-dependent 
individuals (abstinent) 
 27 social drinking controls 
Plasma TNFα, IL10, IL1ra  
Serial sampling: pre and post mental imagery 
(2 conditions: stress, neutral) 
Additional measurements: drug craving 
IL10 baseline:  
Cocaine < Control 
TNFα following stress 
imagery:  
Cocaine > Control 
Loftis et al  
2011 [54] 
 20 methamphetamine-
dependent (abstinent) 
 20 healthy controls 
Plasma IL1β, IL2, IL6, IL10, TNFα, MCP-1, 
MIP-1α, MIP-1β, ICAM-1 
No significant group 
differences. 
Irwin et al 
2007 [34] 
 19 cocaine-dependent men 
(abstinent) 
 19 healthy male controls 
Plasma TNF, IL6  
In vivo: 40 mg cocaine IV and placebo IV 
Serial sampling: pre and every 4 hours post 
treatment 
In vitro: LPS stimulation 
Additional measurements: heart rate variability  
TNF- baseline: 
Cocaine < Control  
TNF and IL6 post 
treatment: 
Cocaine < Placebo 
LPS-stimulated TNF:  
Cocaine < Placebo 
Rios-Olivares 
et al 2006  
[33] 
 30 cocaine and heroin 
dependent individuals with 
hepatitis C (not abstinent) 
 30 healthy controls without 
hepatitis C 
Plasma + supernatants TNFα, IFN, IL1, IL2, 
IL4, IL6, IL10  
In vitro: PHA and PAI stimulation 
TNFα, IFN, IL2,IL4, 
IL6, IL10 
(unstimulated):  
Cocaine > Control  
Halpern et al 
2003 [35] 
 2 x 15 cocaine users  
(not dependent, abstinent) 
Plasma IL6, cortisol, ACTH, DHEA, cocaine 
levels 
In vivo: either IV 0.4mg/kg cocaine or placebo 
Serial sampling: pre / 2 hours post treatment 
Additional measurements: endocrine responses 
IL6 baseline: 
No group differences 
IL6 post treatment: 
Cocaine < Placebo 
Gan et al 
1998 [22] 
 15 cocaine-dependent 
individuals (not abstinent) 
 4 healthy blood donors  
Plasma INF, TNFα,IL1, IL2, IL6 IL10, 
IL12  
Lymphocytes profile: CD4+, CD8+, NK-cells 
INF: Cocaine > baseline 
IL10: Cocaine < baseline 
In vitro stimulation: 
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In vivo:  40 mg cocaine IV, pre/post cocaine  
In vitro: cocaine stimulation in 4 healthy controls 
Cocaine suppressed  
INF and IL10 synthesis 
Ruiz et al 
1998 [25] 
 63 cocaine users (not 
dependent, not abstinent) 
 20 healthy controls 
Lymphocytes profile 
In vitro: PHA, AntiCD3, PMA, IL2 - 
stimulations 
No significant group 
differences in lymphocyte 
profile 
Ruiz et al 
1994 [23] 
 34 cocaine users (not 
dependent, not abstinent) 
 22 healthy controls  
Lymphocytes profile CD4+ and NK-cells: 
Cocaine > Controls 
CD8+ T-cells: 
Cocaine < Controls 
Chen GJ et al 
1991 [32] 
 47 polydrug users with a 
history of cocaine use 
(mainly abstinent) 
 no controls 
Plasma  IL1, IL2, IFN, SIL-2R No relationships between 
cytokine expression and 
severity of drug use. 
Van Dyke et 
al 1986 [24] 
 8 occasional cocaine users 
(abstinent)  
 no controls 
Lymphocytes profile and activity  
In vivo: 0.6mg cocaine or placebo IV  
Serial sampling: pre / post intervention 
NK-cell activity: 
Cocaine > Placebo 
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Figures 
 
 
Figure 1: Comparisons of T-cells, NK-cells and B-cells between 22 actively using stimulant-
dependent individuals and 22 matched healthy control volunteers. (a) The percentage of CD4 T-
cells was significantly increased in the stimulant-dependent group compared with control 
volunteers (t42=3.21, p = 0.003). (b) The percentage of CD8 T-cells (t42=0.11, p = 0.916) and the 
CD4/CD8 ratio did not significantly differ between the groups (t42=0.58, p = 0.568). (c) The 
percentage of NK-cells is significantly reduced in the stimulant-dependent group (t42=2.69, p = 
0.010) compared with the control group. (d) No differences were found with respect to the 
percentage of B-cells (t42=1.79, p=0.081). 
  
Cocaine and Neuro-immune Interactions                 page 16 
Ersche & Döffinger 
Submission to Current Opinion in Behavioral Sciences 
   
References 
A text of particular interest, published within the period of review, have been highlighted as: 
* of special interest, and ** of outstanding interest 
 
 1.  Jones L, Bartes G, Bellis M, Beynon C, Duffy P, Evans-Brown M, Mackridge A, 
McCoy E, Sumnall H, McVeigh J: A summary of the health harms of drugs. London: 
U.K. Department of Health; 2011. 
 2.  EMCDDA: Cocaine and Crack Cocaine: A Growing Public Health Problem. Lisbon, 
Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2007. 
 3.  Dinis-Oliveira RJ, Carvalho F, Duarte JA, Proenca JB, Santos A, Magalhaes T: 
Clinical and forensic signs related to cocaine abuse. Curr Drug Abuse Rev 2012, 
5:64-83. 
 4.  Mena G, Giraudon I, Alvarez E, Corkery JM, Matias J, Grasaasen K, Llorens N, 
Griffiths P, Vicente J: Cocaine-Related Health Emergencies in Europe: A Review 
of Sources of Information, Trends and Implications for Service Development. 
European Addiction Research 2013, 19:74-81. 
 5.  Clark KH, Wiley CA, Bradberry CW: Psychostimulant Abuse and 
Neuroinflammation: Emerging Evidence of Their Interconnection. Neurotox Res 
2013, 23:174-188. 
 6.  Coller JK, Hutchinson MR: Implications of central immune signaling caused by 
drugs of abuse: Mechanisms, mediators and new therapeutic approaches for 
prediction and treatment of drug dependence. Pharmacol Therapeut 2012, 
134:219-245. 
 7.  Marasco CC, Goodwin CR, Winder DG, Schramm-Sapyta NL, Mclean JA, Wikswo 
JP: Systems-level view of cocaine addiction: The interconnection of the immune 
and nervous systems. Experimental Biology and Medicine 2014, 239:1433-1442. 
     ** This article provides a comprehensive review of the current knowledge in the field. It 
covers the effects of cocaine on cell-mediated immunity and humoral immunity as 
well as the involvement of monoamines and the sigma receptor in cocaine mediated 
immunomodulation. 
 
 8.  Volkow ND, Fowler JS, Wang GJ, Swanson JM: Dopamine in drug abuse and 
addiction: results from imaging studies and treatment implications. Mol Psychiatr 
2004, 9:557-569. 
 9.  Johanson CE, Fischman MW: The Pharmacology of Cocaine Related to Its Abuse. 
Pharmacol Rev 1989, 41:3-52. 
 10.  Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang YY, Perez A, 
Frankel WG, Cooper T, Kleber HD, Fischman MW, Laruelle M: Cocaine 
dependence and D2 receptor availability in the functional subdivisions of the 
striatum: Relationship with cocaine-seeking behavior. Neuropsychopharmacol 
2004, 29:1190-1202. 
Cocaine and Neuro-immune Interactions                 page 17 
Ersche & Döffinger 
Submission to Current Opinion in Behavioral Sciences 
   
 11.  Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R, Slifstein M, Van 
Heertum R, Kleber HD: Lower Level of Endogenous Dopamine in Patients With 
Cocaine Dependence: Findings From PET Imaging of D2/D3 Receptors 
Following Acute Dopamine Depletion. Am J Psychiat 2009, 166:1170-1177. 
 12.  Ersche KD, Williams GB, Robbins TW, Bullmore ET: Meta-analysis of structural 
brain abnormalities associated with stimulant drug dependence and 
neuroimaging of addiction vulnerability and resilience. Curr Opin Neurobiol 2013, 
25:615-624. 
 13.  Howe CJ, Fuller CM, Ompad DC, Galea S, Koblin B, Thomas D, Vlahov D: 
Association of sex, hygiene and drug equipment sharing with hepatitis C virus 
infection among non-injecting drug users in New York City. Drug Alcohol Depen 
2005, 79:389-395. 
 14.  Ersche KD, Gillan CM, Jones PS, Williams GB, Ward LHE, Luijten M, de Wit S, 
Sahakian BJ, Bullmore ET, Robbins TW: Carrots and Sticks Fail to Change 
Behavior in Cocaine Addiction. Science 2016, 352:1468-1471. 
 15.  Ersche KD, Hagan CC, Smith DG, Abbott S, Jones PS, Apergis-Schoute AM, 
Döffiner R: Aberrant Disgust Responses and Immune Reactivity in Cocaine-
Dependent Men. Biol Psychiat 2014, 75:140-147. 
 16.  Fischer B, Blanken P, Da Silveira D, Gallassi A, Goldner EM, Rehm J, Tyndall M, 
Wood E: Effectiveness of secondary prevention and treatment interventions for 
crack-cocaine abuse: A comprehensive narrative overview of English-language 
studies. Int J Drug Policy 2015, 26:352-363. 
 17.  Basu S, Dasgupta PS: Dopamine, a neurotransmitter, influences the immune 
system. J Neuroimmunol 2000, 102:113-124. 
 18.  Levite M: Dopamine and T cells: dopamine receptors and potent effects on T 
cells, dopamine production in T cells, and abnormalities in the dopaminergic 
system in T cells in autoimmune, neurological and psychiatric diseases. Acta 
Physiologica 2016, 216:42-89. 
 19.  Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S: The immunoregulatory 
role of dopamine: An update. Brain Behav Immun 2010, 24:525-528. 
       ** This excellent and concise review on the effects of dopamine on immune function is 
easily accessible for neuroscientist. It extends an earlier review by Basu et al (2002). 
 20.  Pacheco R, Contreras F, Zouali M: The dopaminergic system in autoimmune 
diseases. Frontiers in Immunology 2014, 5:1-17. 
 21.  Engler H, Doenlen R, Riether C, Engler A, Niemi MB, Besedovsky HO, del Rey A, 
Pacheco-Lopez G, Feldon J, Schedlowski M: Time-dependent alterations of 
peripheral immune parameters after nigrostriatal dopamine depletion in a rat 
model of Parkinson's disease. Brain Behav Immun 2009, 23:518-526. 
Cocaine and Neuro-immune Interactions                 page 18 
Ersche & Döffinger 
Submission to Current Opinion in Behavioral Sciences 
   
 22.  Gan X, Zhang L, Newton T, Chang SL, Ling W, Kermani V, Berger O, Graves MC, 
Fiala M: Cocaine Infusion Increases Interferon-[gamma] and Decreases 
Interleukin-10 in Cocaine-Dependent Subjects. Clin Immunol Immunop 1998, 
89:181-190. 
 23.  Ruiz P, Cleary T, Nassiri TM, Steele B: Human T-Lymphocyte Subpopulation and 
Nk Cell Alterations in Persons Exposed to Cocaine. Clin Immunol Immunop 1994, 
70:245-250. 
 24.  Van Dyke C, Stesin A, Jones R, Chuntharapai A, Seaman W: Cocaine increases 
natural killer cell activity. J Clin Invest 1986, 77:1387-1390. 
 25.  Ruiz P, Berho M, Steele BW, Hao L: Peripheral human T lymphocyte maintenance 
of immune functional capacity and phenotypic characteristics following in vivo 
cocaine exposure. Clin Immunol Immunop 1998, 88:271-276. 
 26.  Pacheco R, Prado CE, Barrientos MJ, Bernales S: Role of dopamine in the 
physiology of T-cells and dendritic cells. Journal of Neuroimmunology 2009, 216:8-
19. 
 27.  Mikulak J, Bozzo L, Roberto A, Pontarini E, Tentorio P, Hudspeth K, Lugli E, 
Mavilio D: Dopamine Inhibits the Effector Functions of Activated NK Cells via 
the Upregulation of the D5 Receptor. Journal of Immunology 2014, 193:2792-2800. 
 28.  Moreira FP, Carvalho Medeiros JR, Lhullier AC, de Mattos Souza LD, Jansen K, 
Portela LV, Lara DR, da Silva RA, Wiener CD, Oses JP: Cocaine abuse and effects 
in the serum levels of cytokines IL-6 and IL-10. Drug Alcohol Depen 2016, 
158:181-185. 
 29.  Narvaez JC, Magalhaes PV, Fries GR, Colpo GD, Czepielewski LS, Vianna P, Bog 
Chies JA, Rosa AR, Von Diemen L, Vieta E, Pechansky F, Kapczinski F: Peripheral 
toxicity in crack cocaine use disorders. Neurosci Lett 2013, 544:80-84. 
 30.  Araos P, Pedraz M, Serrano A, Lucena M, Barrios V, Garcia-Marchena N, Campos-
Cloute R, Ruiz JJ, Romero P, Suarez J, Baixeras E, de la Torre R, Montesinos J, 
Guerri C, Rodriguez-Arias M, Minarro J, Martinez-Riera R, Torrens M, Chowen JA, 
Argente J, Mason BJ, Pavon FJ, Rodriguez de Fonseca F: Plasma profile of pro-
inflammatory cytokines and chemokines in cocaine users under outpatient 
treatment: influence of cocaine symptom severity and psychiatric co-morbidity. 
Addict Biol 2015, 20:756-772. 
 31.  Levandowski ML, Viola TW, Wearick-Silva LE, Wieck A, Tractenberg SG, Brietzke 
E, Bauer ME, Teixeira AL, Grassi-Oliveira R: Early life stress and tumor necrosis 
factor superfamily in crack cocaine withdrawal. Journal of Psychiatric Research 
2014, 53:180-186. 
 32.  Chen GJ, Pillai R, Erickson JR, Martinez F, Estrada AL, Watson RR: Cocaine 
Immunotoxicity - Abnormal Cytokine Production in Hispanic Drug-Users. 
Toxicology Letters 1991, 59:81-88. 
Cocaine and Neuro-immune Interactions                 page 19 
Ersche & Döffinger 
Submission to Current Opinion in Behavioral Sciences 
   
 33.  Rios-Olivares E, Vila LM, Reyes JC, Rodriguez JW, Colon JH, Pagan NO, Marrero 
A, Rios-Orraca ZM, Boukli NM, Shapshak P, Robles RR: Impaired cytokine 
production and suppressed lymphocyte proliferation activity in HCV-infected 
cocaine and heroin (speedball) users. Drug Alcohol Depen 2006, 85:236-243. 
 34.  Irwin MR, Olmos L, Wang M, Valladares EM, Motivala SJ, Fong T, Newton T, Butch 
A, Olmstead R, Cole SW: Cocaine Dependence and Acute Cocaine Induce 
Decreases of Monocyte Proinflammatory Cytokine Expression across the Diurnal 
Period: Autonomic Mechanisms. J Pharmacol Exp Ther 2007, 320:507-515. 
        * The study described in this article investigates the link between the immune system 
and the autonomic system by monitoring the responses to cocaine in cocaine-
dependent men using serial assessments of cytokine production and heart-rate 
variability measurements. This is an excellent example of how the autonomic system 
mediates the immunomodulatory effects of cocaine. 
 35.  Halpern JH, Sholar MB, Glowacki J, Mello NK, Mendelson JH, Siegel AJ: 
Diminished Interleukin-6 Response to Proinflammatory Challenge in Men and 
Women after Intravenous Cocaine Administration. J Clin Endocrinol Metab 2003, 
88:1188-1193. 
        * This study investigates the mediating effects of the endocrine system on the effects of 
cocaine on the immune system by administering cocaine to healthy individuals’ 
immune system in a placebo-controlled manner. 
 36.  Sternberg EM: Neural regulation of innate immunity: a coordinated nonspecific 
host response to pathogens. Nat Rev Immunol 2006, 6:318-328. 
      ** This review provides an excellent introduction for the non-immunology on the 
relationship between the central nervous and immune systems. 
 37.  Pike JL, Smith TL, Hauger RL, Nicassio PM, Patterson TL, McClintick J, Costlow C, 
Irwin MR: Chronic life stress alters sympathetic, neuroendocrine, and immune 
responsivity to an acute psychological stressor in humans. Psychosom Med 1997, 
59:447-457. 
 38.  Dallman MF: Stress update. Trends in Endocrinology & Metabolism 1993, 4:62-69. 
 39.  Dahal S, Chitti SVP, Nair MPN, Saxena SK: Interactive effects of cocaine on HIV 
infection: implication in HIV-associated neurocognitive disorder and neuroAIDS. 
Frontiers in Microbiology 2015, 6. 
 40.  Swepson C, Ranjan A, Balasubramaniam M, Pandhare J, Dash C: Cocaine Enhances 
HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation. 
Frontiers in Microbiology 2016, 7. 
 41.  Restrepo CS, Rojas CA, Martinez S, Riascos R, Marmol-Velez A, Carrillo J, Vargas 
D: Cardiovascular complications of cocaine: Imaging findings. Emergency 
Radiology 2009, 16:11-19. 
Cocaine and Neuro-immune Interactions                 page 20 
Ersche & Döffinger 
Submission to Current Opinion in Behavioral Sciences 
   
 42.  Goeders NE: The HPA axis and cocaine reinforcement. Psychoneuroendocrino 
2002, 27:13-33. 
 43.  Dantzer R, Kelley KW: Twenty years of research on cytokine-induced sickness 
behavior. Brain, Behavior, and Immunity 2007, 21:153-160. 
 44.  Black PH: Stress and the inflammatory response: A review of neurogenic 
inflammation. Brain Behav Immun 2002, 16:622-653. 
 45.  Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH: Association 
between Plasma IL-6 Response to Acute Stress and Early-Life Adversity in 
Healthy Adults. Neuropsychopharmacol 2010, 35:2617-2623. 
 46.  Pace TWW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, Heim 
CM: Increased stress-induced inflammatory responses in male patients with 
major depression and increased early life stress. Am J Psychiat 2006, 163:1630-
1633. 
 47.  Narvaez JCM, Magalhaes PVS, Trindade EK, Vieira DC, Kauer-Sant'Anna M, Gama 
CS, von Diemen L, Kapczinski NS, Kapczinski F: Childhood trauma, impulsivity, 
and executive functioning in crack cocaine users. Compr Psychiat 2012, 53:238-
244. 
 48.  Ersche KD, Turton AJ, Chamberlain SR, Müller U, Bullmore ET, Robbins TW: 
Cognitive dysfunction and anxious-impulsive personality traits are 
endophenotypes for drug dependence. Am J Psychiat 2012, 169:926-936. 
 49.  Weiss RD, Griffin ML, Mirin SM: Drug Abuse as Self-Medication for Depression: 
An Empirical Study. Am J Drug Alcohol Abuse 1992, 18:121-129. 
 50.  Friedman H, Pross S, Klein TW: Addictive drugs and their relationship with 
infectious diseases. Fems Immunol Med Mic 2006, 47:330-342. 
 51.  Dorshkind K, Montecino-Rodriguez E, Signer RAJ: The ageing immune system: is it 
ever too old to become young again? Nat Rev Immunol 2009, 9:57-62. 
 52.  Ersche KD, Jones PS, Williams GB, Robbins TW, Bullmore ET: Cocaine 
dependence: a fast-track for brain ageing? Mol Psychiatr 2013, 18:134-135. 
 53.  Fox HC, D'Sa C, Kimmerling A, Siedlarz KM, Tuit KL, Stowe R, Sinha R: Immune 
system inflammation in cocaine dependent individuals: implications for 
medications development. Hum Psychopharm Clin 2012, 27:156-166. 
 54.  Loftis JM, Choi D, Hoffman W, Huckans MS: Methamphetamine Causes Persistent 
Immune Dysregulation: A Cross-Species, Translational Report. Neurotox Res 
2011, 20:59-68. 
 
 
